相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease
J. Torres et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Systematic review: management options for primary sclerosing cholangitis and its variant forms-IgG4-associated cholangitis and overlap with autoimmune hepatitis
E. L. Culver et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
John E. Eaton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Primary Sclerosing Cholangitis Associated with Elevated ImmunoglobulinG4: Clinical Characteristics and Response to Therapy
Einar Bjornsson et al.
AMERICAN JOURNAL OF THERAPEUTICS (2011)
Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis
Peter P. Stanich et al.
DIGESTIVE AND LIVER DISEASE (2011)
Primary sclerosing cholangitis
Tom H. Karlsen et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Bile Acid Changes After High-Dose Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis: Relation to Disease Progression
Emmanouil Sinakos et al.
HEPATOLOGY (2010)
In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival
Gerda Rudolph et al.
JOURNAL OF HEPATOLOGY (2010)
Side Chain Structure Determines Unique Physiologic and Therapeutic Properties of norUrsodeoxycholic Acid in Mdr2-/- Mice
Emina Halilbasic et al.
HEPATOLOGY (2009)
Activation of the Cholehepatic Shunt as a Potential Therapy for Primary Sclerosing Cholangitis
Shannon S. Glaser et al.
HEPATOLOGY (2009)
High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
Keith D. Lindor et al.
HEPATOLOGY (2009)
Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis
Gerda Rudolph et al.
JOURNAL OF HEPATOLOGY (2009)
Immunoglobulin G4-associated cholangitis: Clinical profile and response to therapy
Amaar Ghazale et al.
GASTROENTEROLOGY (2008)
The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid
Gerda Rudolph et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice
P Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis
JM Wolf et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
High-dose ursodeoxycholic acid in primary sclerosing cholangitis:: A 5-year multicenter, randomized, controlled study
R Olsson et al.
GASTROENTEROLOGY (2005)
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
DS Pardi et al.
GASTROENTEROLOGY (2003)
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
G Paumgartner et al.
HEPATOLOGY (2002)
Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid:: outcome after endoscopic treatment
A Stiehl et al.
JOURNAL OF HEPATOLOGY (2002)
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'
KN Lazaridis et al.
JOURNAL OF HEPATOLOGY (2001)
Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis
BY Tung et al.
ANNALS OF INTERNAL MEDICINE (2001)
Use of ursodeoxycholic acid in liver diseases
D Kumar et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
分享论文
